Hybrid magnetic nanostructures (MNS) for magnetic resonance imaging applications

Advanced Drug Delivery Reviews

Volumn 63, Issue 14-15, 2011, Pages 1282-1299

  De, Mrinmoy ^a   Chou, Stanley S ^a   Joshi, Hrushikesh M ^a   Dravid, Vinayak P ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Gadolinium; Hybrid MRI; Iron oxide nanoparticle; MRI; MRI contrast agent

Indexed keywords

ASSAY DEVELOPMENT; CLINICAL SETTINGS; CONTRAST AGENT; DUAL MODE AGENTS; HYBRID IMAGING SYSTEMS; IN-VITRO; IN-VIVO; IRON OXIDE NANOPARTICLE; MAGNETIC NANOSTRUCTURES; MRI CONTRAST AGENT; MRI CONTRAST AGENTS; MULTI-MODAL; NANOHYBRIDS; PATIENT CARE; SINGLE MODE; SURFACE FUNCTIONALIZATION;

GADOLINIUM; IRON OXIDES; NANOMAGNETICS; NANOSTRUCTURED MATERIALS; NANOSTRUCTURES;

MAGNETIC RESONANCE IMAGING;

COBALT FERRITE; DEXTRAN; FERUMOSIL; FERUMOXIL; FERUMOXTRAN 10; GADOLINIUM; GADOLINIUM DTTA; GADOLINIUM PENTETATE; GADOTERIC ACID; LIPOCORTIN 5; LIPOSOME; MAGNETIC NANOSTRUCTURE; MAGNETITE; MANGANESE FERRITE; MONOMER; NANOHYBRID; NANOMATERIAL; NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; POLYMER; POLYOL; QUANTUM DOT; RHODAMINE; SILICA NANOPARTICLE; SILICON DIOXIDE; SUPERPARAMAGNETIC IRON OXIDE; TITANIUM DIOXIDE; UNCLASSIFIED DRUG;

CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; HUMAN; IMAGING SYSTEM; MATERIAL COATING; MICELLE; MOLECULAR SIZE; NANOPROBE; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICS; PRIORITY JOURNAL; REVIEW; SURFACE PROPERTY;

ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; DRUG CARRIERS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; METAL NANOPARTICLES; MOLECULAR IMAGING; MOLECULAR STRUCTURE; PARTICLE SIZE; POLYMERS; QUANTUM DOTS; SURFACE PROPERTIES;

EID: 81355138577     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2011.07.001     Document Type: Review

References (149)

1. Brenner D.J., Hall E.J. Current concepts - computed tomography - an increasing source of radiation exposure. The New England Journal of Medicine 2007, 357:2277-2284.
2. Basu S., Chryssikos T., Moghadam-Kia S., Zhuang H.M., Torigian D.A., Alavi A. Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Seminars in Nuclear Medicine 2009, 39:36-51.
3. Meerwaldt R., Slart R.H.J.A., van Dam G.M., Luijckx G.J., Tio R.A., Zeebregts C.J. PET/SPECT imaging: from carotid vulnerability to brain viability. European Journal of Radiology 2010, 74:104-109.
4. Hong R., Fischer N.O., Emrick T., Rotello V.M. Surface PEGylation and ligand exchange chemistry of FePt nanoparticles for biological applications. Chemistry of Materials 2005, 17:4617-4621.
5. Heeger D.J., Ress D. What does fMRI tell us about neuronal activity?. Nature Reviews Neuroscience 2002, 3:142-151.
6. Francois C.J., Schiebler M.L., Reeder S.B. Cardiac MRI evaluation of nonischemic cardiomyopathies. Journal of Magnetic Resonance Imaging 2010, 31:518-530.
7. Seevinck P.R., Deddens L.H., Dijkhuizen R.M. Magnetic resonance imaging of brain angiogenesis after stroke. Angiogenesis 2010, 13:101-111.
8. Caravan P., Ellison J.J., McMurry T.J., Lauffer R.B. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chemical Reviews 1999, 99:2293-2352.
9. De M., Ghosh P.S., Rotello V.M. Applications of nanoparticles in biology. Advanced Materials 2008, 20:4225-4241.
10. Jennings L.E., Long N.J. 'Two is better than one'-probes for dual-modality molecular imaging. Chemical Communications 2009, 3511-3524.
11. Louie A. Multimodality imaging probes: design and challenges. Chemical Reviews 2010, 110:3146-3195.
12. Jin T., Yoshioka Y., Fujii F., Komai Y., Seki J., Seiyama A. Gd3+-functionalized near-infrared quantum dots for in vivo dual modal (fluorescence/magnetic resonance) imaging. Chemical Communications 2008, 5764-5766.
13. Kobayashi Y., Imai J., Nagao D., Takeda M., Ohuchi N., Kasuya A., Konno M. Preparation of multilayered silica-Gd-silica core-shell particles and their magnetic resonance images. Colloids and Surfaces a-Physicochemical and Engineering Aspects 2007, 308:14-19.
14. Xu J.J., Ao Y.H., Fu D.G., Yuan C.W. Synthesis of Gd-doped TiO2 nanoparticles under mild condition and their photocatalytic activity. Colloids and Surfaces a-Physicochemical and Engineering Aspects 2009, 334:107-111.
15. Song Y., Xu X.Y., MacRenaris K.W., Zhang X.Q., Mirkin C.A., Meade T.J. Multimodal gadolinium-enriched DNA-gold nanoparticle conjugates for cellular imaging. Angewandte Chemie, International Edition 2009, 48:9143-9147.
16. Kobayashi H., Brechbiel M.W. Nano-sized MRI contrast agents with dendrimer cores. Advanced Drug Delivery Reviews 2005, 57:2271-2286.
17. Manus L.M., Mastarone D.J., Waters E.A., Zhang X.Q., Schultz-Sikma E.A., MacRenaris K.W., Ho D., Meade T.J. Gd(III)-nanodiamond conjugates for MRI contrast enhancement. Nano Letters 2010, 10:484-489.
18. Sitharaman B., Van Der Zande M., Ananta J.S., Shi X.F., Veltien A., Walboomers X.F., Wilson L.J., Mikos A.G., Heerschap A., Jansen J.A. Magnetic resonance imaging studies on gadonanotube-reinforced biodegradable polymer nanocomposites. Journal of Biomedical Materials Research. Part A 2010, 93A:1454-1462.
19. Endres P.J., Paunesku T., Vogt S., Meade T.J., Woloschak G.E. DNA-TiO2 nanoconjugates labeled with magnetic resonance contrast agents. Journal of the American Chemical Society 2007, 129:15760-15761.
20. Major J.L., Meade T.J. Bioresponsive, cell-penetrating, and multimeric MR contrast agents. Accounts of Chemical Research 2009, 42:893-903.
21. Hu F., Joshi H.M., Dravid V.P., Meade T.J. High-performance nanostructured MR contrast probes. Nanoscale 2010, 2:1884-1891.
22. Modo M.M.J., Bulte J.W.M., Kim E.E. Molecular and cellular MR imaging. Journal of Nuclear Medicine 2007, 48:2087.
23. Roch A., Gossuin Y., Muller R.N., Gillis P. Superparamagnetic colloid suspensions: water magnetic relaxation and clustering. Journal of Magnetism and Magnetic Materials 2005, 293:532-539.
24. Perez J.M., Josephson L., O'Loughlin T., Hogemann D., Weissleder R. Magnetic relaxation switches capable of sensing molecular interactions. Nature Biotechnology 2002, 20:816-820.
25. Perez J.M., O'Loughin T., Simeone F.J., Weissleder R., Josephson L. DNA-based magnetic nanoparticle assembly acts as a magnetic relaxation nanoswitch allowing screening of DNA-cleaving agents. Journal of the American Chemical Society 2002, 124:2856-2857.
26. Hu F., MacRenaris K.W., Waters E.A., Schultz-Sikma E.A., Eckermann A.L., Meade T.J. Highly dispersible, superparamagnetic magnetite nanoflowers for magnetic resonance imaging. Chemical Communications 2010, 46:73-75.
27. Barick K.C., Aslam M., Prasad P.V., Dravid V.P., Bahadur D. Nanoscale assembly of amine-functionalized colloidal iron oxide. Journal of Magnetism and Magnetic Materials 2009, 321:1529-1532.
28. Jun Y.-w., Huh Y.-M., Choi J.-s., Lee J.-H., Song H.-T., Yoon KimKim S., Kim K.-S., Shin J.-S., Suh J.-S., Cheon J. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. Journal of the American Chemical Society 2005, 127:5732-5733.
29. Morales M.P., Veintemillas-Verdaguer S., Montero M.I., Serna C.J., Roig A., Casas L., Martinez B., Sandiumenge F. Surface and internal spin canting in γ-Fe2O3 nanoparticles. Chemistry of Materials 1999, 11:3058-3064.
30. Joshi H.M., Lin Y.P., Aslam M., Prasad P.V., Schultz-Sikma E.A., Edelman R., Meade T., Dravid V.P. Effects of shape and size of cobalt ferrite nanostructures on their MRI contrast and thermal activation. The Journal of Physical Chemistry C 2009, 113:17761-17767.
31. Lee J.-H., Huh Y.-M., Jun Y.-w., Seo J.-w., Jang J.-t., Song H.-T., Kim S., Cho E.-J., Yoon H.-G., Suh J.-S., Cheon J. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nature Medicine 2007, 13:95-99.
32. Pinho S.L.C., Pereira G.A., Voisin P., Kassem J., Bouchaud V.r., Etienne L., Peters J.A., Carlos L., Mornet S.p., Geraldes C.F.G.C., Rocha J.o., Delville M.-H.l.n. Fine tuning of the relaxometry of γ-Fe2O3@SiO2 nanoparticles by tweaking the silica coating thickness. ACS Nano 2010, 4:5339-5349.
33. Lu Y., Yin Y., Mayers B.T., Xia Y. Modifying the surface properties of superparamagnetic iron oxide nanoparticles through a sol-gel approach. Nano Letters 2002, 2:183-186.
34. Ennas G., Musinu A., Piccaluga G., Zedda D., Gatteschi D., Sangregorio C., Stanger J.L., Concas G., Spano G. Characterization of iron oxide nanoparticles in an Fe2O3-SiO2 composite prepared by a sol-gel method. Chemistry of Materials 1998, 10:495-502.
35. Ma D., Veres T., Clime L., Normandin F., Guan J., Kingston D., Simard B. Superparamagnetic FexOy@SiO2 core-shell nanostructures: controlled synthesis and magnetic characterization. The Journal of Physical Chemistry C 2007, 111:1999-2007.
36. Tartaj P., González-Carreño T., Serna C.J. Synthesis of nanomagnets dispersed in colloidal silica cages with applications in chemical separation. Langmuir 2002, 18:4556-4558.
37. Liu Q., Xu Z., Finch J.A., Egerton R. A novel two-step silica-coating process for engineering magnetic nanocomposites. Chemistry of Materials 1998, 10:3936-3940.
38. Aslam M., Li S., Dravid V.P. Controlled synthesis and stability of Co@SiO2 aqueous colloids. Journal of the American Ceramic Society 2007, 90:950-956.
39. del Campo A., Sen T., Lellouche J.-P., Bruce I.J. Multifunctional magnetite and silica-magnetite nanoparticles: synthesis, surface activation and applications in life sciences. Journal of Magnetism and Magnetic Materials 2005, 293:33-40.
40. Hahn P.F., Stark D.D., Lewis J.M., Saini S., Elizondo G., Weissleder R., Fretz C.J., Ferrucci J.T. First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. Radiology 1990, 175:695-700.
41. S.D.D., Hahn P.F., Lewis J.M., Saini S., Elizondo G., Weissleder R., Fretz C.J., Ferrucci J.T. First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. Radiology 1990, 175(3):695-700.
42. Johnson W.K., Stoupis C., Torres G.M., Rosenberg E.B., Ros P.R. Superparamagnetic iron oxide (SPIO) as an oral contrast agent in gastrointestinal (GI) magnetic resonance imaging (MRI): comparison with state-of-the-art computed tomography (CT). Magnetic Resonance Imaging 1996, 14:43-49.
43. Rivera Gil P., Hühn D., del Mercato L.L., Sasse D., Parak W.J. Nanopharmacy: inorganic nanoscale devices as vectors and active compounds. Pharmacological Research 2010, 62:115-125.
44. Stöber W., Fink A., Bohn E. Controlled growth of monodisperse silica spheres in the micron size range. Journal of Colloid and Interface Science 1968, 26:62-69.
45. Lawaczeck R B.H., Frenzel T., Hasegawa M., Ito Y., Kito K., Miwa N., Tsutsui H., Vogler H., Weinmann H.J. Magnetic iron oxide particles coated with carboxydextran for parenteral administration and liver contrasting. Pre-clinical profile of SH U555A. Acta Radiology 1997, 38:584-597.
46. Jung C.W. Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magnetic Resonance Imaging 1995, 13:675-691.
47. Li W., Tutton S., Vu A.T., Pierchala L., Li B.S., Lewis J.M., Prasad P.V., Edelman R.R. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent. Journal of Magnetic Resonance Imaging 2005, 21:46-52.
48. McLachlan S.J., Morris M.R., Lucas M.A., Fisco R.A., Eakins M.N., Fowler D.R., Scheetz R.B., Olukotun A.Y. Phase I clinical evaluation of a new iron oxide MR contrast agent. Journal of Magnetic Resonance Imaging 1994, 4:301-307.
49. Cai W., Wan J. Facile synthesis of superparamagnetic magnetite nanoparticles in liquid polyols. Journal of Colloid and Interface Science 2007, 305:366-370.
50. Seo W.S., Lee J.H., Sun X.M., Suzuki Y., Mann D., Liu Z., Terashima M., Yang P.C., McConnell M.V., Nishimura D.G., Dai H.J. FeCo/graphitic-shell nanocrystals as advanced magnetic-resonance-imaging and near-infrared agents. Nature Materials 2006, 5:971-976.
51. Molday R.S., Mackenzie D. Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. Journal of Immunological Methods 1982, 52:353-367.
52. Yi-Xiang S.M.H.a.G.P.K., Wang1 J. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. European Radiology 2001, 11:2319-2331.
53. Clement O., Siauve N., Cuénod C.-A., Frija G. Liver imaging with ferumoxides (Feridex(R)): fundamentals, controversies, and practical aspects. Topics in Magnetic Resonance Imaging 1998, 9:167-182.
54. Metz S., Bonaterra G., Rudelius M., Settles M., Rummeny E.J., Daldrup-Link H.E. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. European Radiology 2004, 14:1851-1858.
55. Carmen Bautista M., Bomati-Miguel O., del Puerto Morales M., Serna C.J., Veintemillas-Verdaguer S. Surface characterisation of dextran-coated iron oxide nanoparticles prepared by laser pyrolysis and coprecipitation. Journal of Magnetism and Magnetic Materials 2005, 293:20-27.
56. Wunderbaldinger P., Josephson L., Weissleder R. Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents. Academic Radiology 2002, 9:S304-S306.
57. Reimer P., Balzer T. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. European Radiology 2003, 13:1266-1276.
58. Otsuka H., Nagasaki Y., Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Advanced Drug Delivery Reviews 2003, 55:403-419.
59. Nativo P., Prior I.A., Brust M. Uptake and intracellular fate of surface-modified gold nanoparticles. ACS Nano 2008, 2:1639-1644.
60. Niidome T., Yamagata M., Okamoto Y., Akiyama Y., Takahashi H., Kawano T., Katayama Y., Niidome Y. PEG-modified gold nanorods with a stealth character for in vivo applications. Journal of Controlled Release 2006, 114:343-347.
61. You C.C., De M., Rotello V.M. Contrasting effects of exterior and interior hydrophobic moieties in the complexation of amino acid functionalized gold clusters with alpha-chymotrypsin. Organic Letters 2005, 7:5685-5688.
62. Kohler N., Fryxell G.E., Zhang M. A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. Journal of the American Chemical Society 2004, 126:7206-7211.
63. Kim S.-W., Kim S., Tracy J.B., Jasanoff A., Bawendi M.G. Phosphine oxide polymer for water-soluble nanoparticles. Journal of the American Chemical Society 2005, 127:4556-4557.
64. Xu C., Xu K., Gu H., Zheng R., Liu H., Zhang X., Guo Z., Xu B. Dopamine as a robust anchor to immobilize functional molecules on the iron oxide shell of magnetic nanoparticles. Journal of the American Chemical Society 2004, 126:9938-9939.
65. Peng S., Wang C., Xie J., Sun S. Synthesis and stabilization of monodisperse Fe nanoparticles. Journal of the American Chemical Society 2006, 128:10676-10677.
66. Xie J., Xu C., Xu Z., Hou Y., Young K.L., Wang S.X., Pourmand N., Sun S. Linking hydrophilic macromolecules to monodisperse magnetite (Fe3O4) nanoparticles via trichloro-s-triazine. Chemistry of Materials 2006, 18:5401-5403.
67. Amstad E., Gillich T., Bilecka I., Textor M., Reimhult E. Ultrastable iron oxide nanoparticle colloidal suspensions using dispersants with catechol-derived anchor groups. Nano Letters 2009, 9:4042-4048.
68. Wan J., Cai W., Meng X., Liu E. Monodisperse water-soluble magnetite nanoparticles prepared by polyol process for high-performance magnetic resonance imaging. Chemical Communications 2007, 5004-5006.
69. Weissleder R., Cheng H.C., Bogdanova A., Bogdanov A. Magnetically labeled cells can be detected by MR imaging. Journal of Magnetic Resonance Imaging 1997, 7:258-263.
70. Yeh T.C., Zhang W., Ildstad S.T., Ho C. Intracellular labeling of T-cells with superparamagnetic contrast agents. Magnetic Resonance in Medicine 1993, 30:617-625.
71. Yeh T.C., Zhang W., Ildstad S.T., Ho C. In vivo dynamic MRI tracking of rat T-cells labeled with superparamagnetic iron-oxide particles. Magnetic Resonance in Medicine 1995, 33:200-208.
72. Jendelová P., Herynek V., DeCroos J., Glogarová K., Andersson B., Hájek M., Syková E. Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles. Magnetic Resonance in Medicine 2003, 50:767-776.
73. Jendelová P., Herynek V., Urdzíková L., Glogarová K., Kroupová J., Andersson B., Bryja V., Burian M., Hájek M., Syková E. Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. Journal of Neuroscience Research 2004, 76:232-243.
74. Arbab A.S., Yocum G.T., Kalish H., Jordan E.K., Anderson S.A., Khakoo A.Y., Read E.J., Frank J.A. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004, 104:1217-1223.
75. Zhu J., Zhou L., XingWu F. Tracking neural stem cells in patients with brain trauma. The New England Journal of Medicine 2006, 355:2376-2378.
76. Heyn C., Ronald J.A., Mackenzie L.T., MacDonald I.C., Chambers A.F., Rutt B.K., Foster P.J. In vivo magnetic resonance imaging of single cells in mouse brain with optical validation. Magnetic Resonance in Medicine 2006, 55:23-29.
77. Shapiro E.M., Sharer K., Skrtic S., Koretsky A.P. In vivo detection of single cells by MRI. Magnetic Resonance in Medicine 2006, 55:242-249.
78. Artemov D., Mori N., Okollie B., Bhujwalla Z.M. MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magnetic Resonance in Medicine 2003, 49:403-408.
79. McAteer M.A., Sibson N.R., von zur Muhlen C., Schneider J.E., Lowe A.S., Warrick N., Channon K.M., Anthony D.C., Choudhury R.P. In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide. Nature Medicine 2007, 13:1253-1258.
80. Yigit M.V., Mazumdar D., Lu Y. MRI detection of thrombin with aptamer functionalized superparamagnetic iron oxide nanoparticles. Bioconjugate Chemistry 2008, 19:412-417.
81. Pichler B.J., Wehrl H.F., Kolb A., Judenhofer M.S. Positron emission tomography/magnetic resonance imaging: the next generation of multimodality imaging?. Seminars in Nuclear Medicine 2008, 38:199-208.
82. Catana C., Wu Y.B., Judenhofer M.S., Qi J.Y., Pichler B.J., Cherry S.R. Simultaneous acquisition of multislice PET and MR images: initial results with a MR-compatible PET scanner. Journal of Nuclear Medicine 2006, 47:1968-1976.
83. Aime S., Botta M., Fasano M., Terreno E. Lanthanide(III) chelates for NMR biomedical applications. Chemical Society Reviews 1998, 27:19-29.
84. Sturzu A., Regenboyen M., Klose U., Echner H., Gharabaghi A., Heckl S. Novel dual labelled nucleus-directed conjugates containing correct and mutant nuclear localisation sequences. European Journal of Pharmaceutical Sciences 2008, 33:207-216.
85. Xu H., Regino C.A.S., Koyama Y., Hama Y., Gunn A.J., Bernardo M., Kobayashi H., Choyke P.L., Brechbiel M.W. Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence Imaging. Bioconjugate Chemistry 2007, 18:1474-1482.
86. Koullourou T., Natrajan L.S., Bhavsar H., Pope S.J.A., Feng J.H., Narvainen J., Shaw R., Scales E., Kauppinen R., Kenwright A.M., Faulkner S. Synthesis and spectroscopic properties of a prototype single molecule dual Imaging agent comprising a heterobimetallic rhenium-gadolinium complex. Journal of the American Chemical Society 2008, 130:2178-2179.
87. Zhang X.A., Lovejoy K.S., Jasanoff A., Lippard S.J. Water-soluble porphyrins imaging platform for MM zinc sensing. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:10780-10785.
88. Huber M.M., Staubli A.B., Kustedjo K., Gray M.H.B., Shih J., Fraser S.E., Jacobs R.E., Meade T.J. Fluorescently detectable magnetic resonance imaging agents. Bioconjugate Chemistry 1998, 9:242-249.
89. Mishra A., Pfeuffer J., Mishra R., Engelmann J., Mishra A.K., Ugurbil K., Logothetis N.K. A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging. Bioconjugate Chemistry 2006, 17:773-780.
90. Burns A., Ow H., Wiesner U. Fluorescent core-shell silica nanoparticles: towards "Lab on a Particle" architectures for nanobiotechnology. Chemical Society Reviews 2006, 35:1028-1042.
91. Oberdorster G., Stone V., Donaldson K. Toxicology of nanoparticles: a historical perspective. Nanotoxicology 2007, 1:2-25.
92. Rieter W.J., Kim J.S., Taylor K.M.L., An H.Y., Lin W.L., Tarrant T., Lin W.B. Hybrid silica nanoparticles for multimodal Imaging. Angewandte Chemie, International Edition 2007, 46:3680-3682.
93. Kim J.S., Rieter W.J., Taylor K.M.L., An H., Lin W.L., Lin W.B. Self-assembled hybrid nanoparticles for cancer-specific multimodal imaging. Journal of the American Chemical Society 2007, 129:8962-8963.
94. van Schooneveld M.M., Cormode D.P., Koole R., van Wijngaarden J.T., Calcagno C., Skajaa T., Hilhorst J., 't Hart D.C., Fayad Z.A., Mulder W.J.M., Meijerink A. A fluorescent, paramagnetic and PEGylated gold/silica nanoparticle for MRI, CT and fluorescence imaging. Contrast Media & Molecular Imaging 2010, 5:231-236.
95. Gerion D., Herberg J., Bok R., Gjersing E., Ramon E., Maxwell R., Kurhanewicz J., Budinger T.F., Gray J.W., Shuman M.A., Chen F.F. Paramagnetic silica-coated nanocrystals as an advanced MRI contrast agent. The Journal of Physical Chemistry C 2007, 111:12542-12551.
96. Chan W.C.W., Nie S.M. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 1998, 281:2016-2018.
97. Bruchez M., Moronne M., Gin P., Weiss S., Alivisatos A.P. Semiconductor nanocrystals as fluorescent biological labels. Science 1998, 281:2013-2016.
98. Cai W.B., Chen K., Li Z.B., Gambhir S.S., Chen X.Y. Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. Journal of Nuclear Medicine 2007, 48:1862-1870.
99. Schipper M.L., Cheng Z., Lee S.W., Bentolila L.A., Iyer G., Rao J.H., Chen X.Y., Wul A.M., Weiss S., Gambhirl S.S. MicroPET-based biodistribution of quantum dots in living mice. Journal of Nuclear Medicine 2007, 48:1511-1518.
100. Yang H.S., Santra S., Walter G.A., Holloway P.H. Gd-III-functionalized fluorescent quantum dots as multimodal imaging probes. Advanced Materials 2006, 18:2890-2894.
101. Wang S., Jarrett B.R., Kauzlarich S.M., Louie A.Y. Core/shell quantum dots with high relaxivity and photoluminescence for multimodality imaging. Journal of the American Chemical Society 2007, 129:3848-3856.
102. Prinzen L., Miserus R.J.J.H.M., Dirksen A., Hackeng T.M., Deckers N., Bitsch N.J., Megens R.T.A., Douma K., Heemskerk J.W., Kooi M.E., Frederik P.M., Slaaf D.W., van Zandvoort M.A.M.J., Reutelingsperger C.P.M. Optical and magnetic resonance imaging of cell death and platelet activation using annexin A5-functionalized quantum dots. Nano Letters 2007, 7:93-100.
103. Boersma H.H., Kietselaer B.L.J.H., Stolk L.M.L., Bennaghmouch A., Hofstra L., Narula J., Heidendal G.A.K., Reutelingsperger C.P.M. Past, present, and future of annexin A5: from protein discovery to clinical applications. Journal of Nuclear Medicine 2005, 46:2035-2050.
104. Zhang C.F., Jugold M., Woenne E.C., Lammers T., Morgenstern B., Mueller M.M., Zentgraf H., Bock M., Eisenhut M., Semmler W., Kiessling F. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Cancer Research 2007, 67:1555-1562.
105. Mulder W.J.M., Strijkers G.J., Nicolay K., Griffioen A.W. Quantum dots for multimodal molecular imaging of angiogenesis. Angiogenesis 2010, 13:131-134.
106. Mulder W.J.M., Castermans K., van Beijnum J.R., Egbrink M.G.A.O., Chin P.T.K., Fayad Z.A., Lowik C.W.G.M., Kaijzel E.L., Que I., Storm G., Strijkers G.J., Griffioen A.W., Nicolay K. Molecular imaging of tumor angiogenesis using alpha v beta 3-integrin targeted multimodal quantum dots. Angiogenesis 2009, 12:17-24.
107. Mulder W.J.M., Strijkers G.J., Van Tilborg G.A.F., Cormode D.P., Fayad Z.A., Nicolay K. Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging. Accounts of Chemical Research 2009, 42:904-914.
108. Mulder W.J.M., Koole R., Brandwijk R.J., Storm G., Chin P.T.K., Strijkers G.J., Donega C.D., Nicolay K., Griffioen A.W. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Letters 2006, 6:1-6.
109. Santra S., Yang H.S., Holloway P.H., Stanley J.T., Mericle R.A. Synthesis of water-dispersible fluorescent, radio-opaque, and paramagnetic CdS: Mn/ZnS quantum dots: a multifunctional probe for bioimaging. Journal of the American Chemical Society 2005, 127:1656-1657.
110. Mulder W.J.M., Strijkers G.J., Habets J.W., Bleeker E.J.W., van der Schaft D.W.J., Storm G., Koning G.A., Griffioen A.W., Nicolay K. MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle. The FASEB Journal 2005, 19:2008-2010.
111. Vuu K., Xie J.W., McDonald M.A., Bernardo M., Hunter F., Zhang Y.T., Li K., Bednarski M., Guccione S. Gadolinium-rhodamine nanoparticles for cell labeling and tracking via magnetic resonance and optical imaging. Bioconjugate Chemistry 2005, 16:995-999.
112. Kamaly N., Kalber T., Ahmad A., Oliver M.H., So P.W., Herlihy A.H., Bell J.D., Jorgensen M.R., Miller A.D. Bimodal paramagnetic and fluorescent liposomes for cellular and tumor magnetic resonance imaging. Bioconjugate Chemistry 2008, 19:118-129.
113. Vucic E., Sanders H.M.H.F., Arena F., Terreno E., Aimo S., Nicolay K., Leupold E., Dathe M., Sommerdijk N.A.J.M., Fayad Z.A., Mulder W.J.M. Well-defined, multifunctional nanostructures of a paramagnetic lipid and a lipopeptide for macrophage imaging. Journal of the American Chemical Society 2009, 131:406-407.
114. Laurent S., Elst L.V., Wautier M., Galaup C., Muller R.N., Picard C. In vitro characterization of the Gd complex of [2,6-pyridinediylbis(methylene nitrilo)] tetraacetic acid (PMN-tetraacetic acid) and of its Eu analogue, suitable bimodal contrast agents for MRI and optical imaging. Bioorganic & Medicinal Chemistry Letters 2007, 17:6230-6233.
115. Li Z.Q., Zhang Y. Facile synthesis of lanthanide nanoparticles with paramagnetic, down- and up-conversion properties. Nanoscale 2010, 2:1240-1243.
116. Li Z.Q., Zhang Y., Shuter B., Idris N.M. Hybrid lanthanide nanoparticles with paramagnetic shell coated on upconversion fluorescent nanocrystals. Langmuir 2009, 25:12015-12018.
117. Esfand R., Tomalia D.A. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discovery Today 2001, 6:427-436.
118. Kobayashi H., Brechbiel M.W. Dendrimer-based nanosized MRI contrast agents. Current Pharmaceutical Biotechnology 2004, 5:539-549.
119. Sarin H., Kanevsky A.S., Wu H.T., Brimacombe K.R., Fung S.H., Sousa A.A., Auh S., Wilson C.M., Sharma K., Aronova M.A., Leapman R.D., Griffiths G.L., Hall M.D. Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells. Journal of Translational Medicine 2008, 6:1-15.
120. Boswell C.A., Eck P.K., Regino C.A.S., Bernardo M., Wong K.J., Milenic D.E., Choyke P.L., Brechbiel M.W. Synthesis, characterization, and biological evaluation of integrin alpha(v)beta(3)-targeted PAMAM dendrimers. Molecular Pharmaceutics 2008, 5:527-539.
121. Talanov V.S., Regino C.A.S., Kobayashi H., Bernardo M., Choyke P.L., Brechbiel M.W. Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging. Nano Letters 2006, 6:1459-1463.
122. Pittet M.J., Swirski F.K., Reynolds F., Josephson L., Weissleder R. Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles. Nature Protocols 2006, 1:73-79.
123. Manciulea A., Baker A., Lead J.R. A fluorescence quenching study of the interaction of Suwannee River fulvic acid with iron oxide nanoparticles. Chemosphere 2009, 76:1023-1027.
124. Wang A.Z., Bagalkot V., Vasilliou C.C., Gu F., Alexis F., Zhang L., Shaikh M., Yuet K., Cima M.J., Langer R., Kantoff P.W., Bander N.H., Jon S.Y., Farokhzad O.C. Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy. ChemMedChem 2008, 3:1311-1315.
125. Kircher M.F., Weissleder R., Josephson L. A dual fluorochrome probe for imaging proteases. Bioconjugate Chemistry 2004, 15:242-248.
126. Sosnovik D.E., Garanger E., Aikawa E., Nahrendorf M., Figueiredo J.L., Dai G.P., Reynolds F., Rosenzweig A., Weissleder R., Josephson L. Molecular MRI of cardiomyocyte apoptosis with simultaneous delayed enhancement MRI distinguishes apoptotic and necrotic myocytes in vivo: potential for midmyocardial salvage in acute ischemia. Circulation 2009, 120:S367-S367.
127. Sosnovik D.E., Schellenberger E.A., Nahrendorf M., Novikov M.S., Matsui T., Dai G., Reynolds F., Grazette L., Rosenzweig A., Weissleder R., Josephson L. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magnetic Resonance in Medicine 2005, 54:718-724.
128. Wang D.S., He J.B., Rosenzweig N., Rosenzweig Z. Superparamagnetic Fe2O3 Beads-CdSe/ZnS quantum dots core-shell nanocomposite particles for cell separation. Nano Letters 2004, 4:409-413.
129. Chen D.Y., Jiang M.J., Li N.J., Gu H.W., Xu Q.F., Ge J.F., Xia X.W., Lu J.M. Modification of magnetic silica/iron oxide nanocomposites with fluorescent polymethacrylic acid for cancer targeting and drug delivery. Journal of Materials Chemistry 2010, 20:6422-6429.
130. Ma Z.Y., Dosev D., Nichkova M., Dumas R.K., Gee S.J., Hammock B.D., Liu K., Kennedy I.M. Synthesis and characterization of multifunctional silica core-shell nanocomposites with magnetic and fluorescent functionalities. Journal of Magnetism and Magnetic Materials 2009, 321:1368-1371.
131. Lee J.E., Lee N., Kim H., Kim J., Choi S.H., Kim J.H., Kim T., Song I.C., Park S.P., Moon W.K., Hyeon T. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. Journal of the American Chemical Society 2010, 132:552-557.
132. Mandal S.K., Lequeux N., Rotenberg B., Tramier M., Fattaccioli J., Bibette J., Dubertret B. Encapsulation of magnetic and fluorescent nanoparticles in emulsion droplets. Langmuir 2005, 21:4175-4179.
133. Park J.H., von Maltzahn G., Ruoslahti E., Bhatia S.N., Sailor M.J. Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angewandte Chemie, International Edition 2008, 47:7284-7288.
134. Roullier V., Grasset F., Boulmedais F., Artzner F., Cador O., Marchi-Artzner V. Small bioactivated magnetic quantum dot micelles. Chemistry of Materials 2008, 20:6657-6665.
135. Agrawal P., Strijkers G.J., Nicolay K. Chitosan-based systems for molecular imaging. Advanced Drug Delivery Reviews 2010, 62:42-58.
136. Ge Y.Q., Zhang Y., He S.Y., Nie F., Teng G.J., Gu N. Fluorescence modified chitosan-coated magnetic nanoparticles for high-efficient cellular imaging. Nanoscale Research Letters 2009, 4:287-295.
137. Li L.L., Chen D., Zhang Y.Q., Deng Z.T., Ren X.L., Meng X.W., Tang F.Q., Ren J., Zhang L. Magnetic and fluorescent multifunctional chitosan nanoparticles as a smart drug delivery system. Nanotechnology 2007, 18:1-6.
138. Tan W.B., Zhang Y. Multi-functional chitosan nanoparticles encapsulating quantum dots and Gd-DTPA as imaging probes for bio-applications. Journal of Nanoscience and Nanotechnology 2007, 7:2389-2393.
139. Zhang Y.X., Das G.K., Xu R., Tan T.T.Y. Tb-doped iron oxide: bifunctional fluorescent and magnetic nanocrystals. Journal of Materials Chemistry 2009, 19:3696-3703.
140. Selvan S.T., Patra P.K., Ang C.Y., Ying J.Y. Synthesis of silica-coated semiconductor and magnetic quantum dots and their use in the imaging of live cells. Angewandte Chemie, International Edition 2007, 46:2448-2452.
141. Kim Y.B., Bae K.H., Yoo S.S., Park T.G., Park H. Positive contrast visualization for cellular magnetic resonance imaging using susceptibility-weighted echo-time encoding. Magnetic Resonance Imaging 2009, 27:601-610.
142. Zhuo J.C., Gullapalli R.P. AAPM/RSNA physics tutorial for residents - MR artifacts, safety, and quality control. RadioGraphics 2006, 26:U275-U333.
143. Yoon M.A., Kim S.H., Park H.S., Lee D.H., Lee J.Y., Han J.K., Choi B.I. Value of dual contrast liver MRI at 3.0T in differentiating well-differentiated hepatocellular carcinomas from dysplastic nodules preliminary results of multivariate analysis. Investigative Radiology 2009, 44:641-649.
144. Sung C.K., Hong K.A., Lin S., Lee Y., Cha J., Lee J.K., Hong C.P., Han B.S., Jung S.I., Kim S.H., Yoon K.S. Dual-modal nanoprobes for imaging of mesenchymal stem cell transplant by MRI and fluorescence imaging. Korean Journal of Radiology 2009, 10:613-622.
145. Small W.C., Nelson R.C., Bernardino M.E. Dual contrast enhancement of both T1-weighted and T2-weighted sequences using ultrasmall superparamagnetic iron-oxide. Magnetic Resonance Imaging 1993, 11:645-654.
146. Corot C., Robert P., Idee J.M., Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Advanced Drug Delivery Reviews 2006, 58:1471-1504.
147. De Cuyper M., Soenen S.J.H., Coenegrachts K., Ter Beek L. Surface functionalization of magnetoliposomes in view of improving iron oxide-based magnetic resonance imaging contrast agents: anchoring of gadolinium ions to a lipophilic chelate. Analytical Biochemistry 2007, 367:266-273.
148. Choi J.S., Lee J.H., Shin T.H., Song H.T., Kim E.Y., Cheon J. Self-confirming 'AND' logic nanoparticles for fault-free MRI. Journal of the American Chemical Society 2010, 132:11015-11017.
149. Bae K.H., Kim Y.B., Lee Y., Hwang J., Park H., Park T.G. Bioinspired synthesis and characterization of gadolinium-labeled magnetite nanoparticles for dual contrast T-1- and T-2-weighted magnetic resonance imaging. Bioconjugate Chemistry 2010, 21:505-512.